Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

There are currently no FDA approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030

News | Pharmaceuticals

Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in PH-HFpEF

May 31, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

May 31, 2023

A new report, “Digital Transformation in Healthcare Market,” from Future Market Insights, Inc., found that by the end of 2023, the fast-paced sector is expected to be worth $65.2 billion.

News | Cardiovascular Business

Healthcare Digital Transformation Market Report Forecasts Major Growth thru 2033

May 31, 2023 — A new report is shedding light on the fast pace of growth in the digital heath sector at present and over ...

May 31, 2023

The objective of this study was to assess the safety and efficacy of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery (PA).

News | Drug-Eluting Balloons

Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

May 30, 2023 — Twelve-month results from the SELUTION SFA trial have been presented for the first time at the Japan ...

May 30, 2023

Through ACC Global Quality Solutions Program, Dnipro hospital CV teams are enhancing skills and raising quality of care for local heart attack patients

News | ACC

Ukraine Hospital Improving Emergency Cardiovascular Care During National Crisis

May 26, 2023 — The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in Ukr ...

May 26, 2023

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients

News | Heart Failure

European Study Finds the Abbott Cardiomems Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated¹ heart failure ...

May 26, 2023

Emile Daoud, MD, helped develop a new surgical device at The Ohio State University Wexner Medical Center to prevent a common and serious complication during heart ablation procedures. The device gently moves the nearby esophagus away from the heart to prevent the ablation energy from causing damage.

News | Atrial Fibrillation

New Device Helps Prevent Complication During Common Heart Procedure

May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans ...

May 26, 2023

Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE Pulsed Field Ablation System

News | Left Atrial Appendage (LAA) Occluders

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

May 25, 2023

Feature | Cardiovascular Business

Wainscot Media Names New Diagnostic and Interventional Cardiology Group Publisher

May 24, 2023 — Park Ridge, N.J.-based publisher Wainscot Media has named Laura Dowden as managing director, group ...

May 24, 2023

The system treats severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT).

News | Structural Heart

Medtronic Harmony Transcatheter Pulmonary Valve Demonstrates Strong 2-year Outcomes

May 24, 2023 — Medtronic announced two-year results of their Harmony Transcatheter Pulmonary Valve (TPV) System, which ...

May 24, 2023

global collaboration between medical technology leaders Abbott and Stereotaxis

News | Robotic Systems

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

May 24, 2023 — Stereotaxis announced a global collaboration with Abbott to integrate Abbott’s EnSite X EP System with ...

May 24, 2023

PARAGLIDE-HF trial presented in a late breaking science session today at Heart Failure 2023

News | Heart Failure

Sacubitril/Valsartan Shows Benefit in Heart Failure with Ejection Fraction Above 40%

May 23, 2023 — Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone ...

May 23, 2023

Greater Glasgow and Clyde Population Analysis presented in a late breaking science session today at Heart Failure 2023

News | Heart Failure

The Diagnosis of Heart Failure is More Often Missed than Made Especially for Women

May 23, 2023 — The diagnosis of heart failure is usually missed, denying patients treatments that could improve ...

May 23, 2023

MONITOR-HF trial presented in a late breaking science session at Heart Failure 2023

News | Heart Failure

Remote Monitoring Reduces Heart Failure Hospitalizations and Improves Quality of Life

May 23, 2023 — The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it ...

May 23, 2023

Results from global trial of the POLARx Cryoablation System* meet safety and effectiveness endpoints

News | Left Atrial Appendage (LAA) Occluders

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

May 22, 2023

Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves

News | Structural Heart

New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease

May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of ...

May 19, 2023